WASHINGTON, D.C – Following a surge of new COVID-19 cases in the United States, ACLA President Julie Khani issued the following statement: “ACLA member laboratories ... Read More
WASHINGTON, D.C. – Following additional guidance released today from the Department of Labor, the Department of Treasury, and the Department of Health and Human Services ... Read More
In a bipartisan letter to Secretary Azar, 30 lawmakers urge HHS to designate funds to help clinical laboratories expand capacity WASHINGTON, D.C. – As clinical ... Read More
WASHINGTON, D.C. – As ACLA reviews the new data reporting guidance released today by the Department of Health and Human Services (HHS), ACLA President Julie Khani ... Read More
WASHINGTON, D.C. – Following the release by the Centers for Medicare and Medicaid Services (CMS) of a reimbursement rate of $42.13 for the most commonly-performed ... Read More
WASHINGTON, D.C. — Following the introduction of the ‘‘Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act” ACLA President Julie Khani issued the following statement: “ACLA is currently ... Read More
WASHINGTON, D.C. — Following the Trump Administration’s announcements today on expanding access to testing, ACLA President Julie Khani released the following statement: “After scaling up to meet an ... Read More
WASHINGTON, D.C. — Following ongoing developments related to COVID-19 testing and response, ACLA President Julie Khani issued the following statement: “Labs are not scaling back. We’re ramping ... Read More
WASHINGTON, D.C. – Following the revised policy on serologic testing announced today by the Food and Drug Administration, ACLA President Julie Khani issued the following ... Read More
WASHINGTON, D.C. – Following today’s meeting at the White House, ACLA President Julie Khani issued the following statement: “ACLA appreciated the opportunity to meet today ... Read More